Eleonora Assanto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eleonora Assanto has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Adolfo Marco Perrotta
Nephrology Unit, Department of Translational and Precision Medicine, Policlinico Umberto I University Hospital, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication - Antonietta Gigante
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
1 shared publication - Francesca Tinti
Nephrology Unit, Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication - Maurizio Muscaritoli
Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication - Rosario Cianci
Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication - Silvia Lai
Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 15 June 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (12) , 7175
Assessment of Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited kidney disease which leads to progressive kidney failure. About 5–10% of patients requiring renal replacement therapy are affected by ADPKD. Cardiovascular diseases are the main causes of morbidity and mortality in these patients with ADPKD; arterial hypertension (AH) is the first symptom with a very early onset. Anyway, some other cardiovascular abnormalities have been reported in ADPKD regardless of the presence of AH. With this background, we conducted a systematic review, collecting all randomized controlled trials (RCTs) and quasi-RCTs found on the main databases; we evaluated the evidence about different imaging techniques to grade the cardiovascular risk in a very early stage of disease. This review aims to describe all cardiovascular assessments in ADPKD patients to improve clinicians’ ability to discover cardiovascular involvement early, allowing appropriate therapies promptly.
- 15 June 2023
- Published by MDPI AG in Applied Sciences
- Vol. 13 (12) , 7175
Open AccessAssessment of Cardiovascular Disease in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited kidney disease which leads to progressive kidney failure. About 5–10% of patients requiring renal replacement therapy are affected by ADPKD. Cardiovascular diseases are the main causes of morbidity and mortality in these patients with ADPKD; arterial hypertension (AH) is the first symptom with a very early onset. Anyway, some other cardiovascular abnormalities have been reported in ADPKD regardless of the presence of AH. With this background, we conducted a systematic review, collecting all randomized controlled trials (RCTs) and quasi-RCTs found on the main databases; we evaluated the evidence about different imaging techniques to grade the cardiovascular risk in a very early stage of disease. This review aims to describe all cardiovascular assessments in ADPKD patients to improve clinicians’ ability to discover cardiovascular involvement early, allowing appropriate therapies promptly.